JP2000247830A - Elastase inhibitor - Google Patents
Elastase inhibitorInfo
- Publication number
- JP2000247830A JP2000247830A JP11050347A JP5034799A JP2000247830A JP 2000247830 A JP2000247830 A JP 2000247830A JP 11050347 A JP11050347 A JP 11050347A JP 5034799 A JP5034799 A JP 5034799A JP 2000247830 A JP2000247830 A JP 2000247830A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- elastase
- inhibitor
- guava
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、エラスターゼ阻害
活性を有し、皮膚の弾力やハリを維持することにより皮
膚の老化を防止し、若々しく瑞々しい肌の状態を維持す
ることができるエラスターゼ阻害剤、特に化粧料の形態
に調製したエラスターゼ阻害剤に関する。TECHNICAL FIELD The present invention has an elastase inhibitory activity, can prevent skin aging by maintaining elasticity and firmness of the skin, and can maintain a young and fresh skin condition. The present invention relates to an elastase inhibitor, particularly an elastase inhibitor prepared in the form of a cosmetic.
【0002】[0002]
【従来の技術】皮膚の老化によって生じる外観の変化の
代表例としては、シワやタルミの発生、あるいはハリの
減少などがあり、特に紫外線暴露によって生じた皮膚の
老化を光老化と称している。エラスチンは、真皮細胞外
マトリックスの2〜4%を占める弾力線維である。紫外
線暴露によりエラスチン分解酵素であるエラスターゼが
過剰に発現することによって、このエラスチンが変性お
よび分解されることが、皮膚の弾力性低下につながると
考えられている[Cosmetics & Toiletries magazine, Vo
l.113, 51-58, 1998]。従って、エラスターゼの働きを
抑え、皮膚に弾力やハリを与えるエラスチンの変性およ
び分解を抑制することが、皮膚の老化防止に重要であ
る。しかし、安全性が高く、かつ効果が十分なエラスタ
ーゼ阻害剤はこれまで得られていないのが現状である。2. Description of the Related Art A typical example of a change in appearance caused by aging of the skin is the occurrence of wrinkles or lumps or a decrease in firmness. In particular, aging of the skin caused by exposure to ultraviolet rays is called photoaging. Elastin is an elastic fiber that makes up 2-4% of the dermal extracellular matrix. It is thought that the overexpression of elastase, an elastin-degrading enzyme, due to exposure to ultraviolet light causes the elastin to be denatured and degraded, leading to a decrease in skin elasticity [Cosmetics & Toiletries magazine, Voss
l.113, 51-58, 1998]. Therefore, it is important to prevent the aging of the skin by suppressing the action of elastase and suppressing the denaturation and decomposition of elastin which gives the skin elasticity and firmness. However, at present, an elastase inhibitor with high safety and sufficient effect has not been obtained so far.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、エラ
スターゼの活性を抑えて皮膚の弾力やハリを回復および
維持することにより、皮膚の老化を防止し、若々しく瑞
々しい肌の状態を維持する効果を持つエラスターゼ阻害
剤を提供することである。SUMMARY OF THE INVENTION It is an object of the present invention to prevent aging of the skin by suppressing the activity of elastase to restore and maintain the elasticity and firmness of the skin, and to provide a young and fresh skin condition. An object of the present invention is to provide an elastase inhibitor having an effect of maintaining the elastase inhibitor.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記課題
を解決するために、種々の植物抽出物についてエラスタ
ーゼ阻害活性を調べた結果、グアバ、ガラナ、ローズマ
リー、オトギリソウ、ボタンピ、ホップ、シャクヤク、
ソウハクヒおよびモッカの抽出物が目的の効果を有する
ことを見出し、本発明を完成するに至った。Means for Solving the Problems In order to solve the above problems, the present inventors examined elastase inhibitory activity of various plant extracts, and found that guava, guarana, rosemary, hypericum, buttonpi, hop, Peonies,
The present inventors have found that extracts of sow scab and mocca have the desired effects, and have completed the present invention.
【0005】即ち、本発明は、グアバ、ガラナ、ローズ
マリー、オトギリソウ、ボタンピ、ホップ、シャクヤ
ク、ソウハクヒおよびモッカからなる群から選ばれる1
種または2種以上の植物の抽出物を有効成分として含有
することを特徴とするエラスターゼ阻害剤を提供するも
のである。本発明の好ましい態様においては、該エラス
ターゼ阻害剤を化粧料の形態に調製する。[0005] That is, the present invention relates to a method selected from the group consisting of guava, guarana, rosemary, hypericum, buttonpi, hop, peony, soybean and mocca.
It is intended to provide an elastase inhibitor comprising an extract of a species or two or more plants as an active ingredient. In a preferred embodiment of the present invention, the elastase inhibitor is prepared in the form of a cosmetic.
【0006】[0006]
【発明の実施の形態】以下において本発明を詳しく説明
する。抽出に用いるグアバ、ガラナ、ローズマリー、オ
トギリソウ、ボタンピ、ホップ、シャクヤク、ソウハク
ヒおよびモッカは、その全草、地上部、葉、根皮、茎、
根、枝、果実、種子もしくは花のいずれか、またはこれ
ら植物部位の2以上を混合したものであってもよい。こ
れら植物原料は生であってもよいし、乾燥物であっても
よい。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail. Guava, guarana, rosemary, hypericum, buttonpips, hops, peonies, soybeans, and mokka used for extraction are the whole grass, the above-ground parts, leaves, root bark, stems,
Any of roots, branches, fruits, seeds or flowers, or a mixture of two or more of these plant parts may be used. These plant raw materials may be raw or dried.
【0007】好ましくは、グアバはフトモモ科植物バン
ジンロウ(Psidium guajava)の葉、ガラナはムクロジ科
植物ガラナ(Paullinia cupana)の種子、ローズマリーは
シソ科植物マンネンロウ(Rosmarinus officinalis)の全
草、オトギリソウはオトギソウ科植物オトギリソウ(Hyp
ericum erectum )の全草、ボタンピはボタン科植物ボタ
ン(Paeonia suffruticosa)の根皮、ホップはクワ科植物
ホップ(Humulus lupulus)の花、シャクヤクはボタン科
植物シャクヤク(Paeonia lactiflora)の根、ソウハクヒ
はクワ科植物ヤマグワ(Morus bombycis)の根皮、モッカ
はバラ科植物カリン(Chaenomeles sinensis)の果実を用
い、これら植物原料を粉砕した後、抽出に用いる。[0007] Preferably, guava is a leaf of Psidium guajava, a guarana is a seed of Paulinia cupana, a rosemary is a whole plant of a perilla plant, Rosmarinus officinalis, and a hypericum is St. John's wort. Family Hypericum perforatum (Hyp
ericum erectum), the buttonpi is the root bark of the button family plant (Paeonia suffruticosa), the hop is the flower of the mulberry plant hop (Humulus lupulus), the peonies are the roots of the button family plant peonies (Paeonia lactiflora), and The root bark and mokka of the family plant Yamaguwa (Morus bombycis) use the fruits of the rose family plant karin (Chaenomeles sinensis), and these plant materials are pulverized and used for extraction.
【0008】本発明において用いるグアバ、ガラナ、ロ
ーズマリー、オトギリソウ、ボタンピ、ホップ、シャク
ヤク、ソウハクヒおよびモッカの抽出物とは、上記植物
原料を常温または加温下に溶媒抽出することによって得
られる抽出液、その希釈液もしくは濃縮液、またはその
乾燥物を意味する。本発明においては、上記植物の2種
以上を混合して抽出を行うことができ、また、各植物の
抽出物を混合して用いることができる。The extract of guava, guarana, rosemary, hypericum, buttonpi, hops, peonies, soybeans and mocca used in the present invention is an extract obtained by extracting the above-mentioned plant material with a solvent at room temperature or under heating. , Its diluent or concentrate, or its dried product. In the present invention, two or more of the above plants can be mixed for extraction, and the extracts of each plant can be mixed and used.
【0009】本発明においては、エラスターゼ阻害効果
の点から、グアバ、ガラナ、ローズマリー、オトギリソ
ウ、ボタンピ、ホップおよびモッカの抽出物を用いるの
が好ましい。さらに好ましくは、グアバ、ローズマリー
およびボタンピの抽出物を用いる。In the present invention, it is preferable to use extracts of guava, guarana, rosemary, hypericum, buttonpi, hop and mocca from the viewpoint of elastase inhibitory effect. More preferably, extracts of guava, rosemary and buttoned peas are used.
【0010】抽出に用いる溶媒としては、水、または低
級アルコール(メチルアルコール、エチルアルコールま
たはブタノールなど)、アセトン、酢酸エチル、1,3-
ブチレングリコールもしくはプロピレングリコールなど
の有機溶媒の1種または2種以上を適宜混合して使用す
ることができる。As the solvent used for the extraction, water, lower alcohols (such as methyl alcohol, ethyl alcohol or butanol), acetone, ethyl acetate, and 1,3-
One or more kinds of organic solvents such as butylene glycol or propylene glycol can be used by being appropriately mixed.
【0011】抽出は通常の方法で行ってよい。抽出温度
は、通常は4〜120℃、好ましくは40〜120℃の
範囲である。抽出時間は、抽出温度によって変化する
が、通常、室温付近で抽出する場合は1〜10日間であ
り、40℃以上で抽出する場合は0.5〜120時間で
ある。[0011] The extraction may be performed in a usual manner. The extraction temperature is usually in the range of 4 to 120C, preferably 40 to 120C. Although the extraction time varies depending on the extraction temperature, it is generally 1 to 10 days for extraction near room temperature, and 0.5 to 120 hours for extraction at 40 ° C. or higher.
【0012】このようにして得た抽出液をそのままで本
発明のエラスターゼ阻害剤に用いることができるが、こ
の抽出液を濃縮あるいは適当な溶媒(例えば、水または
低級アルコール)で希釈して用いることもできる。ま
た、この抽出液を蒸発乾固して本発明のエラスターゼ阻
害剤に用いることもできる。The extract thus obtained can be used as it is for the elastase inhibitor of the present invention. However, this extract is concentrated or diluted with an appropriate solvent (eg, water or lower alcohol) before use. Can also. Further, the extract can be evaporated to dryness and used as the elastase inhibitor of the present invention.
【0013】本発明のエラスターゼ阻害剤は、外用の形
態、特に化粧料および浴用剤の形態に調製する。化粧料
としては、ジェル状クリーム、洗顔クリーム、化粧水、
乳液などが挙げられ、浴用剤としては、固体および液体
のものが挙げられる。The elastase inhibitor of the present invention is prepared in the form for external use, especially in the form of cosmetics and baths. As cosmetics, gel cream, face wash cream, lotion,
Emulsions and the like can be mentioned, and examples of bath preparations include solid and liquid ones.
【0014】本発明のエラスターゼ阻害剤中の植物抽出
物の配合割合は、植物抽出物の濃度およびエラスターゼ
阻害剤の形態によって異なるが、通常はエラスターゼ阻
害剤全量に対して0.0001〜99重量%、好ましく
は0.001〜10重量%、より好ましくは0.001〜
5重量%の範囲である。The mixing ratio of the plant extract in the elastase inhibitor of the present invention varies depending on the concentration of the plant extract and the form of the elastase inhibitor, but is usually 0.0001 to 99% by weight based on the total amount of the elastase inhibitor. , Preferably 0.001 to 10% by weight, more preferably 0.001 to 10% by weight.
It is in the range of 5% by weight.
【0015】本発明のエラスターゼ阻害剤は、活性成分
である植物抽出物の他に、種々のエラスターゼ阻害剤の
形態に応じてそれらを調製する際に一般的に使用される
各種成分を含有する。これら成分は、例えば、油分、界
面活性剤、保湿剤、贈粘剤、防腐剤、香料、着色料、薬
剤などである。The elastase inhibitor of the present invention contains, in addition to the plant extract as an active ingredient, various components generally used in preparing various elastase inhibitors according to their forms. These components are, for example, oils, surfactants, humectants, thickeners, preservatives, fragrances, colorings, drugs and the like.
【0016】[0016]
【実施例】以下に実施例を挙げて本発明を具体的に説明
するが、本発明はこれら実施例に限定されるものではな
い。EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.
【0017】実施例1 グァバ抽出物の調製 グアバ30gを50%エタノール水溶液300mLに浸
漬し、室温にて1週間抽出した。不溶物を濾過し、濾液
を蒸発させて固形分を約6.0g得た。 Example 1 Preparation of Guava Extract 30 g of guava was immersed in 300 mL of a 50% aqueous ethanol solution and extracted at room temperature for one week. The insolubles were filtered off and the filtrate was evaporated, yielding about 6.0 g of solids.
【0018】実施例2 ガラナ抽出物の調製 ガラナ30gを50%エタノール水溶液300mLに浸
漬し、室温にて1週間抽出した。不溶物を濾過し、濾液
を蒸発させて固形分を約6.2g得た。 Example 2 Preparation of Guarana Extract 30 g of guarana was immersed in 300 mL of a 50% aqueous ethanol solution and extracted at room temperature for one week. The insolubles were filtered off and the filtrate was evaporated, yielding about 6.2 g of solid.
【0019】実施例3 ローズマリー抽出物の調製 ローズマリー30gを50%エタノール水溶液300m
Lに浸漬し、室温にて1週間抽出した。不溶物を濾過
し、濾液を蒸発させて固形分を約3.7g得た。 Example 3 Preparation of rosemary extract 30 g of rosemary was added to 300 m of a 50% aqueous ethanol solution.
L and extracted for 1 week at room temperature. The insolubles were filtered off and the filtrate was evaporated, yielding about 3.7 g of solid.
【0020】実施例4 オトギリソウ抽出物の調製 オトギリソウ30gを50%エタノール水溶液300m
Lに浸漬し、室温にて1週間抽出した。不溶物を濾過
し、濾液を蒸発させて固形分を約4.6g得た。 Example 4 Preparation of Hypericum perforatum extract 30 g of Hypericum perforatum was added to 300 m of a 50% aqueous ethanol solution.
L and extracted for 1 week at room temperature. The insolubles were filtered off and the filtrate was evaporated, yielding about 4.6 g of solids.
【0021】実施例5 ボタンピ抽出物の調製 ボタンピ30gを50%エタノール水溶液300mLに
浸漬し、室温にて1週間抽出した。不溶物を濾過し、濾
液を蒸発させて固形分を約7.4g得た。 Example 5 Preparation of a buttonpi extract 30 g of a buttonpi extract was immersed in 300 mL of a 50% aqueous ethanol solution and extracted at room temperature for one week. The insolubles were filtered off and the filtrate was evaporated, yielding about 7.4 g of solids.
【0022】実施例6 ホップ抽出物の調製 ホップ30gを50%エタノール水溶液300mLに浸
漬し、室温にて1週間抽出した。不溶物を濾過し、濾液
を蒸発させて固形分を約10.5g得た。 Example 6 Preparation of Hop Extract 30 g of hops were immersed in 300 mL of a 50% aqueous ethanol solution and extracted at room temperature for one week. The insolubles were filtered off and the filtrate was evaporated, yielding about 10.5 g of solid.
【0023】実施例7 シャクヤク抽出物の調製 シャクヤク30gを50%エタノール水溶液300mL
に浸漬し、室温にて1週間抽出した。不溶物を濾過し、
濾液を蒸発させて固形分を約10.0g得た。 Example 7 Preparation of a peony extract 30 g of a peony extract was added to 300 mL of a 50% aqueous ethanol solution.
And extracted at room temperature for one week. Filter the insoluble matter,
The filtrate was evaporated to give about 10.0 g of solid.
【0024】実施例8 ソウハクヒ抽出物の調製 ソウハクヒ30gを50%エタノール水溶液300mL
に浸漬し、室温にて1週間抽出した。不溶物を濾過し、
濾液を蒸発させて固形分を約4.0g得た。 Example 8 Preparation of Sophora oleracea extract 30 g of Sophora oleracea in 300 mL of a 50% aqueous ethanol solution
And extracted at room temperature for one week. Filter the insoluble matter,
The filtrate was evaporated to give about 4.0 g of solid.
【0025】実施例9 モッカ抽出物の調製 モッカ30gを50%エタノール水溶液300mLに浸
漬し、室温にて1週間抽出した。不溶物を濾過し、濾液
を蒸発させて固形分を約10.0g得た。 Example 9 Preparation of Mokka Extract 30 g of mokka was immersed in 300 mL of 50% aqueous ethanol solution and extracted at room temperature for one week. The insolubles were filtered off and the filtrate was evaporated, yielding about 10.0 g of solid.
【0026】比較例1 クララ抽出物(比較品)の調製 クララ30gを50%エタノール水溶液300mLに浸
漬し、室温にて1週間抽出した。不溶物を濾過し、濾液
を蒸発させて固形分を約6.3g得た。 Comparative Example 1 Preparation of Clara extract (comparative product) 30 g of Clara was immersed in 300 mL of a 50% aqueous ethanol solution and extracted at room temperature for one week. The insolubles were filtered off and the filtrate was evaporated, yielding about 6.3 g of solids.
【0027】実施例10 エラスターゼ阻害活性の測定 反応緩衝液として、0.1M HEPES、0.5M Na
Cl(pH7.4)を用い、エラスターゼとして、ヒト白血
球由来のエラスターゼ(ELASTIN PRODUCT CO., INC.)を
用いた。このエラスターゼを5μg/mLになるように
反応緩衝液に溶解し、96ウエルプレートに25μLづ
つ分注した。さらに、上記の植物抽出物(実施例1〜実
施例9および比較例1で調製)のそれぞれを400μg
/mLになるように反応緩衝液に溶解して植物抽出物溶
液を調製し、これらの溶液を上記の96ウエルプレート
にそれぞれ50μLづつ添加した。37℃で15分間加
温し、次いで、氷上でエラスターゼ基質として8mMの
メトキシ-スクシニル-アラニル-アラニル-プロリル-バ
リン-p-ニトロアニリド(ELASTIN PRODUCT CO., INC.)2
5μLを加え、37℃で30分間加温した。30分後、
直ちに415nmでの吸光度を測定した。比較品とし
て、既にエラスターゼ阻害活性を有することが知られて
いるクララ抽出物(特開平10−17460)を用いた。
エラスターゼ阻害率は以下の式により求めた: Example 10 Measurement of Elastase Inhibitory Activity As a reaction buffer, 0.1 M HEPES and 0.5 M Na were used.
Elastase derived from human leukocytes (ELASTIN PRODUCT CO., INC.) Was used as elastase using Cl (pH 7.4). This elastase was dissolved in a reaction buffer so as to have a concentration of 5 μg / mL, and 25 μL of the solution was dispensed into a 96-well plate. Furthermore, 400 μg of each of the above plant extracts (prepared in Examples 1 to 9 and Comparative Example 1)
/ ML was dissolved in a reaction buffer to prepare a plant extract solution, and these solutions were added to the 96-well plate at 50 μL each. Warm at 37 ° C. for 15 minutes and then on ice 8 mM methoxy-succinyl-alanyl-alanyl-prolyl-valine-p-nitroanilide (ELASTIN PRODUCT CO., INC.) 2 as elastase substrate
5 μL was added, and the mixture was heated at 37 ° C. for 30 minutes. 30 minutes later,
The absorbance at 415 nm was measured immediately. As a comparative product, Clara extract (JP-A-10-17460), which is already known to have elastase inhibitory activity, was used.
Elastase inhibition was determined by the following equation:
【数1】エラスターゼ阻害率(%) = [1−(A1/A0)]
x 100 [式中、A1は阻害剤存在下の吸光度であり、A0は対照
(阻害剤無添加)の吸光度である]。## EQU1 ## Elastase inhibition rate (%) = [1- (A 1 / A 0 )]
x 100 where A 1 is the absorbance in the presence of the inhibitor and A 0 is the control
(No inhibitor added)].
【0028】これらの結果を以下の表1に示す。The results are shown in Table 1 below.
【表1】 上記の結果から、これら植物抽出物にエラスターゼ阻害
活性があることが明らかとなった。特に、グアバ、ロー
ズマリーおよびボタンピの抽出物が高いエラスターゼ阻
害活性を持ち、次いでガラナ、オトギリソウ、モッカお
よびホップの抽出物が高い活性を持ち、次いでソウハク
ヒ、シャクヤクの順で活性が高いことがわかった。ま
た、これらのエラスターゼ阻害活性は、既にエラスター
ゼ阻害活性を有することが知られているクララ抽出物よ
り高いことがわかった。[Table 1] The above results revealed that these plant extracts have elastase inhibitory activity. In particular, it was found that the extracts of guava, rosemary and buttonpi have high elastase inhibitory activity, then the extracts of guarana, hypericum, mocca and hops have high activity, and then the activities of soybean and peonies are higher. . It was also found that these elastase inhibitory activities were higher than Clara extract already known to have elastase inhibitory activity.
【0029】以下に本発明のエラスターゼ阻害剤の種々
の剤型を例示する。実施例11 乳液 下記処方の乳液を調製した。Hereinafter, various dosage forms of the elastase inhibitor of the present invention will be exemplified. Example 11 Emulsion An emulsion having the following formulation was prepared.
【表2】 成分Aを加熱溶解し、80℃に保持する。別に80℃で
加熱溶解した成分Bを成分Aに加え、十分混合する。撹
拌しながら冷却を行い、50℃にて成分Cを加え、乳液
を得た。[Table 2] The component A is dissolved by heating and kept at 80 ° C. Separately, add Component B heated and dissolved at 80 ° C. to Component A, and mix well. The mixture was cooled while stirring, and the component C was added at 50 ° C. to obtain an emulsion.
【0030】実施例12 化粧水 下記処方の化粧水を調製した。 Example 12 Lotion A lotion having the following formulation was prepared.
【表3】 全成分を室温にて撹拌および混合して均一な溶液とし、
pH5.5に調整して化粧水を得た。[Table 3] Stir and mix all components at room temperature to make a homogeneous solution,
The pH was adjusted to 5.5 to obtain a lotion.
【0031】実施例13 クリーム 下記処方のクリームを調製した。 Example 13 Cream A cream having the following formulation was prepared.
【表4】 精製水にプロピレングリコールを加え、加熱して70℃
に保つ(水相)。他の成分を混合し、加熱融解して70℃
に保つ(油相)。水相に油相を加え、予備乳化を行い、次
にホモミキサーで均一に乳化してクリームを得た。[Table 4] Add propylene glycol to purified water, heat to 70 ° C
(Aqueous phase). Mix other ingredients, heat and melt at 70 ° C
(Oil phase). The oil phase was added to the water phase, preliminarily emulsified, and then uniformly emulsified with a homomixer to obtain a cream.
【0032】実施例14 実施例12の化粧水において、植物抽出物を、グアバ抽
出物としたものを発明品1、ガラナ抽出物としたものを
発明品2、ローズマリー抽出物としたものを発明品3、
オトギリソウ抽出物としたものを発明品4、ホップ抽出
物としたものを発明品5、シャクヤク抽出物としたもの
を発明品6、ボタンピ抽出物としたものを発明品7、ソ
ウハクヒ抽出物としたものを発明品8、モッカ抽出物と
したものを発明品9とし、植物抽出物の代わりに精製水
を用いて調製したものを比較品として、20歳から60
歳の女性50人を対象に2ヶ月間の使用試験(顔面塗
布、1日1回)を行った。 Example 14 In the lotion of Example 12, invention extract 1 was obtained by using a guava extract as a plant extract, invention product 2 was obtained by using a guarana extract, and invention was obtained using a rosemary extract. Article 3,
Invention product 4 as a hypericum extract, invention product 5 as a hop extract, invention product 6 as a peony extract, invention product 7 as a peanut extract, and soybean extract From the age of 20 as a comparative product, a product prepared using purified water in place of the plant extract as a comparative product
A two-month use test (face application, once a day) was performed on 50 year-old women.
【0033】試験後の(A)シワおよび小ジワならびに
(B)肌のハリおよびタルミの状態を、試験開始前の状態
と比較することにより、本発明のエラスターゼ阻害剤の
改善効果を評価した。評価は、皮膚の状態を目視にて観
察し、以下の評価基準に基づいて行った。 (A)シワおよび小ジワの評価基準 ++:きれいに消えた; +:少し目立たなくなった; ±:変化なし; −:増えた。 (B)肌のハリおよびタルミの評価基準 ++:非常に改善された; +:改善された; ±:変化なし; −:ハリがなくなったり、タルミが増えた。 尚、この試験において、皮膚に異常をきたした被験者は
いなかった。(A) Wrinkles and wrinkles after the test and
(B) The improvement effect of the elastase inhibitor of the present invention was evaluated by comparing the skin firmness and the skin condition with the condition before the start of the test. The evaluation was performed by visually observing the condition of the skin and based on the following evaluation criteria. (A) Evaluation criteria for wrinkles and fine wrinkles ++: Clearly disappeared; +: Slightly less noticeable; ±: No change;-: Increased. (B) Evaluation criteria for skin firmness and tarumi ++: greatly improved; +: improved; ±: no change;-: no firmness or more thickening. In this test, no subject had abnormal skin.
【0034】これらの結果を以下の表5および表6に示
す。The results are shown in Tables 5 and 6 below.
【表5】 [Table 5]
【表6】 上記の結果から、グアバ抽出物、ガラナ抽出物、ローズ
マリー抽出物、オトギリソウ抽出物、ホップ抽出物、シ
ャクヤク抽出物、ボタンピ抽出物、ソウハクヒ抽出物ま
たはモッカ抽出物を含有することを特徴とするエラスタ
ーゼ阻害剤は、シワおよび小ジワならびに肌のハリおよ
びタルミの改善に効果があることが認められた。[Table 6] From the above results, elastase characterized by containing a guava extract, a guarana extract, a rosemary extract, a hypericum extract, a hop extract, a peony extract, a peanut extract, a soybean extract or a mocca extract The inhibitor was found to be effective in improving wrinkles and fine wrinkles, as well as skin firmness and tallness.
【0035】[0035]
【発明の効果】上記のように、グアバ抽出物、ガラナ抽
出物、ローズマリー抽出物、オトギリソウ抽出物、ホッ
プ抽出物、シャクヤク抽出物、ボタンピ抽出物、ソウハ
クヒ抽出物およびモッカ抽出物は、優れたエラスターゼ
阻害活性を示し、また、これらの植物抽出物を含有する
エラスターゼ阻害剤は、シワおよび小ジワならびに肌の
ハリおよびタルミの改善を示した。As described above, guava extract, guarana extract, rosemary extract, hypericum extract, hop extract, peonies extract, peanut extract, soybean extract and mocca extract are excellent. Elastase inhibitory activities, and elastase inhibitors containing these plant extracts, showed improvement in wrinkles and fine wrinkles, as well as skin firmness and tallness.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 35/78 A61K 35/78 Q (72)発明者 小坂 邦男 兵庫県神戸市西区室谷2丁目2番3号 長 瀬産業株式会社研究開発センター内 Fターム(参考) 4C083 AA111 AA112 AA122 AB032 AB352 AC022 AC072 AC092 AC102 AC122 AC132 AC182 AC242 AC302 AC352 AC422 AC432 AC482 AD092 AD222 AD512 CC01 CC04 CC05 DD23 DD31 EE12 FF05 4C088 AB12 AB32 AB34 AB38 AB51 AB57 AB58 AC01 AC02 AC04 AC05 AC11 BA09 BA10 CA03 MA63 NA14 ZA89 ZC20 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification FI FI Theme Court ゛ (Reference) A61K 35/78 A61K 35/78 Q (72) Inventor Kunio Kosaka 2- 2-3 Muroya, Nishi-ku, Kobe-shi, Hyogo Prefecture No. Nagase & Co., Ltd. R & D Center F-term (reference) 4C083 AA111 AA112 AA122 AB032 AB352 AC022 AC072 AC092 AC102 AC122 AC132 AC182 AC242 AC302 AC352 AC422 AC432 AC482 AD092 AD222 AD512 CC01 CC04 CC05 DD23 DD31 EE12 FF05 4C088 AB12 AB32 AB34 AB AB57 AB58 AC01 AC02 AC04 AC05 AC11 BA09 BA10 CA03 MA63 NA14 ZA89 ZC20
Claims (2)
リソウ、ボタンピ、ホップ、シャクヤク、ソウハクヒお
よびモッカからなる群から選ばれる1種または2種以上
の植物の抽出物を有効成分として含有することを特徴と
するエラスターゼ阻害剤。1. An active ingredient comprising one or more plant extracts selected from the group consisting of guava, guarana, rosemary, hypericum, buttonpi, hops, peonies, soybeans and mocca. Elastase inhibitor.
のエラスターゼ阻害剤。2. The elastase inhibitor according to claim 1, which is prepared in the form of a cosmetic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11050347A JP2000247830A (en) | 1999-02-26 | 1999-02-26 | Elastase inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11050347A JP2000247830A (en) | 1999-02-26 | 1999-02-26 | Elastase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000247830A true JP2000247830A (en) | 2000-09-12 |
Family
ID=12856393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11050347A Pending JP2000247830A (en) | 1999-02-26 | 1999-02-26 | Elastase inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000247830A (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002029986A (en) * | 2000-07-19 | 2002-01-29 | Pola Chem Ind Inc | Corium collagen fiber bundle-restructuring agent and composition containing the same |
JP2002087975A (en) * | 2000-09-13 | 2002-03-27 | Pias Arise Kk | Agent for suppressing production of nitrogen monoxide and skin care preparation, cosmetic and quasi-drug formulating the same agent therein |
JP2002293738A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Cosmetic for improving photoaged skin |
JP2002356406A (en) * | 2001-05-29 | 2002-12-13 | Noevir Co Ltd | Skin care preparation |
JP2003183122A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Agent for inhibiting activity of collagenase |
JP2003183171A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Elastase activity inhibitor |
JP2005008541A (en) * | 2003-06-18 | 2005-01-13 | Akita Prefecture | Collagenase inhibitor and food containing the same |
EP1454620A3 (en) * | 2003-03-06 | 2005-04-13 | Kao Corporation | Skin aging-preventing or improving agent |
EP1951185A1 (en) * | 2005-10-27 | 2008-08-06 | Pele Nova Biotecnologia S.A. | Topical formulation containing latex or fraction thereof, and cosmetic treatment method |
FR2912310A1 (en) * | 2007-02-13 | 2008-08-15 | Kasan Sarl | Cosmetic or pharmaceutical compositions comprise allium and citrus extracts and a combination of paullinia and theobroma extracts or a combination of a salix extract and zinc sulfate |
JP2009108104A (en) * | 2002-11-19 | 2009-05-21 | Basf Beauty Care Solutions France Sas | Test method of activity of substance which may be effective in inhibiting enzyme activity of phospholipase a2 |
JP2010514774A (en) * | 2006-12-29 | 2010-05-06 | エイボン プロダクツ インコーポレーテッド | Composition for improving skin condition and appearance and method of use thereof |
JP2011184346A (en) * | 2010-03-08 | 2011-09-22 | Maruzen Pharmaceut Co Ltd | Hyaluronic acid production promoter and cosmetic |
JP2012087112A (en) * | 2010-09-21 | 2012-05-10 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2013018716A (en) * | 2011-07-07 | 2013-01-31 | Kao Corp | Mfap-4 production promoter |
JP2015151388A (en) * | 2014-02-18 | 2015-08-24 | 共栄化学工業株式会社 | cosmetic |
JP2016056205A (en) * | 2016-01-14 | 2016-04-21 | 花王株式会社 | Mfap-4 production promoter |
JP2017178850A (en) * | 2016-03-30 | 2017-10-05 | 株式会社アイビー化粧品 | Skin external preparation |
US10357531B2 (en) | 2013-11-08 | 2019-07-23 | Legacy Healthcare Ltd. | Method for the management of cancer and cancer treatment-related comorbidities |
US10675313B2 (en) * | 2005-11-17 | 2020-06-09 | BASF Beauty Care Solutions France | HAS2-stimulating plant extracts |
JP2020111540A (en) * | 2019-01-12 | 2020-07-27 | 株式会社桃谷順天館 | Kallikrein 7 precursor production promoter by plant-derived extract, kallikrein 7 activity promoter, epidermal keratinocyte proliferation agent, stratum corneum-thickening improving agent, turnover improver, skin elasticity improver, or hyperkeratosis improver |
US11219592B2 (en) | 2013-10-16 | 2022-01-11 | Legacy Healthcare (Switzerland) Sa | Use of a composition for the pigmentation of hair and hairs |
-
1999
- 1999-02-26 JP JP11050347A patent/JP2000247830A/en active Pending
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002029986A (en) * | 2000-07-19 | 2002-01-29 | Pola Chem Ind Inc | Corium collagen fiber bundle-restructuring agent and composition containing the same |
JP2002087975A (en) * | 2000-09-13 | 2002-03-27 | Pias Arise Kk | Agent for suppressing production of nitrogen monoxide and skin care preparation, cosmetic and quasi-drug formulating the same agent therein |
JP2002293738A (en) * | 2001-03-30 | 2002-10-09 | Sansho Seiyaku Co Ltd | Cosmetic for improving photoaged skin |
JP2002356406A (en) * | 2001-05-29 | 2002-12-13 | Noevir Co Ltd | Skin care preparation |
JP2003183122A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Agent for inhibiting activity of collagenase |
JP2003183171A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Elastase activity inhibitor |
JP2012224637A (en) * | 2002-11-19 | 2012-11-15 | Basf Beauty Care Solutions France Sas | Method of testing activity of potentially active substance to inhibit enzymatic activity of phospholipase a2 |
JP2009108104A (en) * | 2002-11-19 | 2009-05-21 | Basf Beauty Care Solutions France Sas | Test method of activity of substance which may be effective in inhibiting enzyme activity of phospholipase a2 |
EP1454620A3 (en) * | 2003-03-06 | 2005-04-13 | Kao Corporation | Skin aging-preventing or improving agent |
JP2005008541A (en) * | 2003-06-18 | 2005-01-13 | Akita Prefecture | Collagenase inhibitor and food containing the same |
EP1951185A1 (en) * | 2005-10-27 | 2008-08-06 | Pele Nova Biotecnologia S.A. | Topical formulation containing latex or fraction thereof, and cosmetic treatment method |
EP1951185A4 (en) * | 2005-10-27 | 2009-11-11 | Pele Nova Biotecnologia S A | Topical formulation containing latex or fraction thereof, and cosmetic treatment method |
US10675313B2 (en) * | 2005-11-17 | 2020-06-09 | BASF Beauty Care Solutions France | HAS2-stimulating plant extracts |
JP2010514774A (en) * | 2006-12-29 | 2010-05-06 | エイボン プロダクツ インコーポレーテッド | Composition for improving skin condition and appearance and method of use thereof |
JP2014177498A (en) * | 2007-02-13 | 2014-09-25 | Legacy Healthcare Ltd | Method for controlling and/or stabilizing conditions which affect skin |
FR2912310A1 (en) * | 2007-02-13 | 2008-08-15 | Kasan Sarl | Cosmetic or pharmaceutical compositions comprise allium and citrus extracts and a combination of paullinia and theobroma extracts or a combination of a salix extract and zinc sulfate |
US8361522B2 (en) | 2007-02-13 | 2013-01-29 | Legacy Healthcare Holding Ltd | Cosmetic and/or pharmaceutical compositions and their applications |
EP2606874A3 (en) * | 2007-02-13 | 2013-08-14 | Legacy Healthcare Holding Ltd. | Novel cosmetic and/or pharmaceutical compositions and uses thereof |
US8652543B2 (en) | 2007-02-13 | 2014-02-18 | Legacy Healthcare Holding Ltd. | Cosmetic and/or pharmaceutical compositions and their applications |
WO2008113912A3 (en) * | 2007-02-13 | 2008-12-11 | Legacy Healthcare Holding Ltd | Novel cosmetic and/or pharmaceutical compositions and applications thereof |
JP2011184346A (en) * | 2010-03-08 | 2011-09-22 | Maruzen Pharmaceut Co Ltd | Hyaluronic acid production promoter and cosmetic |
JP2012087112A (en) * | 2010-09-21 | 2012-05-10 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2013018716A (en) * | 2011-07-07 | 2013-01-31 | Kao Corp | Mfap-4 production promoter |
US11219592B2 (en) | 2013-10-16 | 2022-01-11 | Legacy Healthcare (Switzerland) Sa | Use of a composition for the pigmentation of hair and hairs |
US10357531B2 (en) | 2013-11-08 | 2019-07-23 | Legacy Healthcare Ltd. | Method for the management of cancer and cancer treatment-related comorbidities |
JP2015151388A (en) * | 2014-02-18 | 2015-08-24 | 共栄化学工業株式会社 | cosmetic |
JP2016056205A (en) * | 2016-01-14 | 2016-04-21 | 花王株式会社 | Mfap-4 production promoter |
JP2017178850A (en) * | 2016-03-30 | 2017-10-05 | 株式会社アイビー化粧品 | Skin external preparation |
JP2020111540A (en) * | 2019-01-12 | 2020-07-27 | 株式会社桃谷順天館 | Kallikrein 7 precursor production promoter by plant-derived extract, kallikrein 7 activity promoter, epidermal keratinocyte proliferation agent, stratum corneum-thickening improving agent, turnover improver, skin elasticity improver, or hyperkeratosis improver |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000247830A (en) | Elastase inhibitor | |
US5674497A (en) | Hair growth promoter comprising extract of mulberry root bark and persimmon and/or paulownia, or extract of persimmon and paulownia | |
JP4918202B2 (en) | Skin composition | |
JP2802434B2 (en) | Lipid peroxide production inhibitor consisting of plant extract | |
US8025908B2 (en) | Topical hair care formulation and method of making | |
KR102093543B1 (en) | Composition for washing hair and scalp to prevent hair losing and to promote hair growth and method for preparing the same | |
JP2000044439A (en) | Composition for scalp and hair treatment | |
JPH11315008A (en) | Antiaging agent | |
EP1175908A1 (en) | Oleoresin of hypericum perforatum l., method for obtaining said oleoresin and the use thereof | |
KR101229762B1 (en) | External Composition for promoting hair growth and preventing alopecia | |
JP4152102B2 (en) | Hair growth promoter composition | |
KR940001125B1 (en) | Thirosinase interfering drug composition containing chrysanthemum moriflium ramat extracts | |
KR101574248B1 (en) | Cosmetic composition comprising Reynoutria sachalinensis extracts for skin anti-wrinkle effect | |
KR20170088055A (en) | Cosmetic composition for improving skin wrinkle containing plant extract removed chlorophyll | |
ES2367523T3 (en) | COSMETIC COMPOSITION CONTAINING CYNARA CARDUNCULUS OR SILYBUM MARIANUM OILS. | |
JP2011001326A (en) | ENDOTHELIN-1 mRNA EXPRESSION INHIBITOR | |
US8586105B2 (en) | Topical hair care formulation and method of making | |
JP5389334B2 (en) | Vascular endothelial growth factor production promoter and hair growth hair external preparation | |
KR20090059445A (en) | Composition for preventing alopecia or growing hair containing the cation/anion mixed surfactant comprising the extracts of medical herbs | |
JP2011001328A (en) | INHIBITOR ON INCREASE IN BASIC FIBROBLAST CELL PROLIFERATION FACTOR mRNA EXPRESSION | |
KR100331675B1 (en) | External skin preparation | |
KR101810585B1 (en) | Cosmetic compositions for slimming containing Fagopyrum esculentum, Ginkgo biloba and Nelumbo Nucifera Leaf complex extract, Sodium Deoxycholate and Tyrosine | |
KR101558185B1 (en) | Composition for improving condition of hair and scalp containing plant extracts | |
JP7315940B2 (en) | fibroblast growth factor-5 expression inhibitor | |
JP2005179334A (en) | Cosmetic composition containing panax ginseng c.a. meyer extract |